Evaluate Adherence to Treatment With Glucophage Sachets Versus Tablets in Diabetes Type 2 Patients Previously Treated With Metformin Tablets

Evaluate Adherence to Treatment With Glucophage Sachets Versus Tablets in Diabetes Type 2 Patients, Previously Treated With Metformin Tablets

This is an open-label, multicenter, two-arm, parallel, randomized phase 4 study to compare the compliance in diabetes type 2 patients treated with Glucophage sachets versus patients treated with Glucophage tablets.

Inclusion Criteria:

• Diabetes mellitus type 2 diagnosed (Baseline Glycemia > 7,0 mmol/L (126 mg/dL) or overload Glycemia > 11,0 mmol/L (198 mg/dL)
• On treatment with metformin tablets
• Patients with at least 2 treated co-morbidities
• Established dose of Metformin > 1.700 mg/day
• Age > 18 years old
• Given informed consent

Exclusion Criteria:

• Patients not able to take medication orally
• According to Summary of Product Characteristics (SmPC)
• Participating in another clinical trial 30 days prior to randomization
• Any other illness or medical or psychiatric condition, severe and uncontrolled that could interfere in the patient's participation or in the assessment of the study results